685 related articles for article (PubMed ID: 14687986)
1. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
Richter K; Pinto do O P; Hägglund AC; Wahlin A; Carlsson L
Haematologica; 2003 Dec; 88(12):1336-47. PubMed ID: 14687986
[TBL] [Abstract][Full Text] [Related]
2. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.
Kometani K; Aoki M; Kawamata S; Shinozuka Y; Era T; Taniwaki M; Hattori M; Minato N
Cancer Res; 2006 Oct; 66(20):9967-76. PubMed ID: 17047059
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow connexin-43 expression is critical for hematopoietic regeneration after chemotherapy.
Presley CA; Lee AW; Kastl B; Igbinosa I; Yamada Y; Fishman GI; Gutstein DE; Cancelas JA
Cell Commun Adhes; 2005; 12(5-6):307-17. PubMed ID: 16531325
[TBL] [Abstract][Full Text] [Related]
4. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells.
Gross AW; Ren R
Oncogene; 2000 Dec; 19(54):6286-96. PubMed ID: 11175343
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice expressing the p75 CCAAT-displacement protein/Cut homeobox isoform develop a myeloproliferative disease-like myeloid leukemia.
Cadieux C; Fournier S; Peterson AC; Bédard C; Bedell BJ; Nepveu A
Cancer Res; 2006 Oct; 66(19):9492-501. PubMed ID: 17018605
[TBL] [Abstract][Full Text] [Related]
6. Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia.
Cuenco GM; Ren R
Oncogene; 2001 Dec; 20(57):8236-48. PubMed ID: 11781838
[TBL] [Abstract][Full Text] [Related]
7. NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice.
Kroon E; Thorsteinsdottir U; Mayotte N; Nakamura T; Sauvageau G
EMBO J; 2001 Feb; 20(3):350-61. PubMed ID: 11157742
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of chronic myeloproliferative syndromes using the technics of in vitro hematopoiesis (the origin and function of marrow stromal cells in CML)].
Takahashi M; Fujiwara M
Rinsho Ketsueki; 1988 Jul; 29(7):994-1000. PubMed ID: 3184486
[No Abstract] [Full Text] [Related]
9. Differences between normal and CML stem cells: potential targets for clinical exploitation.
Eaves AC; Barnett MJ; Ponchio L; Cashman JD; Petzer AL; Eaves CJ
Stem Cells; 1998; 16 Suppl 1():77-83; discussion 89. PubMed ID: 11012149
[TBL] [Abstract][Full Text] [Related]
10. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
[TBL] [Abstract][Full Text] [Related]
11. CD97 is differentially expressed on murine hematopoietic stem-and progenitor-cells.
van Pel M; Hagoort H; Hamann J; Fibbe WE
Haematologica; 2008 Aug; 93(8):1137-44. PubMed ID: 18603564
[TBL] [Abstract][Full Text] [Related]
12. Searching for leukemia stem cells--not yet the end of the road?
Jordan CT
Cancer Cell; 2006 Oct; 10(4):253-4. PubMed ID: 17045202
[TBL] [Abstract][Full Text] [Related]
13. Chronic radiation-induced alteration in hematopoietic repair during preclinical phases of aplastic anemia and myeloproliferative disease: assessing unscheduled DNA synthesis responses.
Seed TM; Meyers SM
Cancer Res; 1993 Oct; 53(19):4518-27. PubMed ID: 8402623
[TBL] [Abstract][Full Text] [Related]
14. Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia.
Yasuda T; Shirakata M; Iwama A; Ishii A; Ebihara Y; Osawa M; Honda K; Shinohara H; Sudo K; Tsuji K; Nakauchi H; Iwakura Y; Hirai H; Oda H; Yamamoto T; Yamanashi Y
J Exp Med; 2004 Dec; 200(12):1681-7. PubMed ID: 15611294
[TBL] [Abstract][Full Text] [Related]
15. [Clonality and stem cell defects in the molecular pathology of chronic myeloproliferative disorders].
Kreipe H; Radzun HJ; Bartels H; von Heyden HW; Löffler H; Parwaresch MR
Verh Dtsch Ges Pathol; 1990; 74():49-64. PubMed ID: 1708635
[TBL] [Abstract][Full Text] [Related]
16. Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells.
Jiang X; Saw KM; Eaves A; Eaves C
J Natl Cancer Inst; 2007 May; 99(9):680-93. PubMed ID: 17470736
[TBL] [Abstract][Full Text] [Related]
17. Shp-2 heterozygous hematopoietic stem cells have deficient repopulating ability due to diminished self-renewal.
Chan RJ; Li Y; Hass MN; Walter A; Voorhorst CS; Shelley WC; Yang Z; Orschell CM; Yoder MC
Exp Hematol; 2006 Sep; 34(9):1230-9. PubMed ID: 16939816
[TBL] [Abstract][Full Text] [Related]
18. The Wilms' tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis.
Hosen N; Shirakata T; Nishida S; Yanagihara M; Tsuboi A; Kawakami M; Oji Y; Oka Y; Okabe M; Tan B; Sugiyama H; Weissman IL
Leukemia; 2007 Aug; 21(8):1783-91. PubMed ID: 17525726
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of PDGF-B in murine hematopoietic cells induces a lethal myeloproliferative syndrome in vivo.
Yan XQ; Brady G; Iscove NN
Oncogene; 1994 Jan; 9(1):163-73. PubMed ID: 8302575
[TBL] [Abstract][Full Text] [Related]
20. Rho GTPases and regulation of hematopoietic stem cell localization.
Williams DA; Zheng Y; Cancelas JA
Methods Enzymol; 2008; 439():365-93. PubMed ID: 18374178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]